We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alibaba
BABA
$283B
| $3.54B | 4.4% |
19,377,902
-285,046
| -1% | -$47.9M |
|
2
Microsoft
MSFT
$2.95T
| $1.59B | 1.98% |
13,504,143
-526,543
| -4% | -$57.4M |
|
3
Meta Platforms (Facebook)
META
$1.63T
| $1.5B | 1.87% |
9,006,781
-241,189
| -3% | -$38.4M |
|
4
Alphabet (Google) Class A
GOOGL
$4.24T
| $1.49B | 1.86% |
25,372,460
+88,620
| +0.4% | +$5M |
|
5
Huazhu Hotels Group
HTHT
$12.3B
| $1.25B | 1.56% |
29,679,530
+1,852,392
| +7% | +$63.3M |
|
6
Amazon
AMZN
$2.66T
| $1.11B | 1.38% |
12,447,680
+222,700
| +2% | +$18.5M |
|
7
Energy Transfer Partners
ET
$69.7B
| $938M | 1.17% |
61,052,996
-13,869,512
| -19% | -$206M |
|
8
S&P Global
SPGI
$128B
| $887M | 1.1% |
4,213,907
+80,700
| +2% | +$15.6M |
|
9
ICICI Bank
IBN
$108B
| $836M | 1.04% |
72,989,361
-1,321,650
| -2% | -$13.7M |
|
10
UnitedHealth
UNH
$396B
| $810M | 1.01% |
3,276,657
-168,335
| -5% | -$42.9M |
|
|
11
Yum China
YUMC
$14.7B
| $771M | 0.96% |
17,160,157
+7,804,046
| +83% | +$307M |
|
12
Merck
MRK
$312B
| $745M | 0.93% |
9,385,083
-150,143
| -2% | -$11.2M |
|
13
Intuit
INTU
$79.3B
| $741M | 0.92% |
2,835,267
+40,936
| +1% | +$9.46M |
|
14
JPMorgan Chase
JPM
$918B
| $739M | 0.92% |
7,304,209
-337,712
| -4% | -$34.8M |
|
15
Elevance Health
ELV
$85.3B
| $707M | 0.88% |
2,464,719
-33,635
| -1% | -$9.73M |
|
16
Citigroup
C
$223B
| $676M | 0.84% |
10,862,715
-352,253
| -3% | -$21.9M |
|
17
Agilent Technologies
A
$37.5B
| $671M | 0.84% |
8,353,256
-54,873
| -0.7% | -$4.17M |
|
|
18
Apple
AAPL
$4.81T
| $664M | 0.83% |
13,977,436
-5,200,308
| -27% | -$221M |
|
|
TGE
19
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
| $643M | 0.8% |
25,575,788
-1,121,649
| -4% | -$26.6M |
|
20
Motorola Solutions
MSI
$67.4B
| $627M | 0.78% |
4,465,388
+52,720
| +1% | +$6.84M |
|
21
Advanced Micro Devices
AMD
$888B
| $625M | 0.78% |
24,489,979
+254,425
| +1% | +$5.78M |
|
|
NBIS
22
Nebius Group N.V.
NBIS
$55.1B
| $622M | 0.77% |
18,126,070
-239,199
| -1% | -$7.93M |
|
23
Adobe
ADBE
$90.3B
| $618M | 0.77% |
2,318,997
+47,057
| +2% | +$11.9M |
|
24
PayPal
PYPL
$49.3B
| $609M | 0.76% |
5,863,776
-85,682
| -1% | -$8.11M |
|
25
Philip Morris
PM
$293B
| $597M | 0.74% |
6,748,548
+342,073
| +5% | +$27.6M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.